Lara Longpre, Chief Development Officer at Mirum Pharmaceuticals, Inc. (MIRM), sold 961 shares at $19.26 ($19K) on 2021-10-01, disclosed to the SEC on 2021-10-01.
Open-market sale of $19k MIRM by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2024-02-05 | $22K | — | Filing → |
| MIRM | SELL | 2024-01-09 | $29K | — | Filing → |
| MIRM | SELL | 2023-07-05 | $26K | — | Filing → |